Australia markets open in 4 hours 25 minutes

Eagle Pharmaceuticals, Inc. (EGRX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
33.51-0.58 (-1.70%)
At close: 04:00PM EST
33.51 -0.00 (-0.00%)
After hours: 04:07PM EST
Currency in USD
Earnings estimateCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
No. of analysts3233
Avg. Estimate0.830.927.54.49
Low estimate0.570.817.243.7
High estimate0.991.047.675.48
Year ago EPS0.854.042.597.5
Revenue estimateCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
No. of analysts3233
Avg. Estimate64.26M61M320.16M271.45M
Low estimate55.08M58.9M310.99M245.6M
High estimate74.8M63.1M330.7M321.8M
Year ago sales42.32M115.87M171.55M320.16M
Sales growth (year/est)51.80%-47.40%86.60%-15.20%
Earnings history30/12/202130/03/202229/06/202229/09/2022
Est. EPS0.943.883.360.91
Actual EPS0.854.041.561.12
Difference-0.090.16-1.80.21
Surprise %-9.60%4.10%-53.60%23.10%
EPS trendCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
Current estimate0.830.927.54.49
7 days ago0.830.927.54.49
30 days ago0.91.047.584.42
60 days ago0.91.047.584.42
90 days ago0.670.867.143.19
EPS revisionsCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesEGRXIndustrySector(s)S&P 500
Current qtr.-2.40%N/AN/AN/A
Next qtr.-77.20%N/AN/AN/A
Current year189.60%N/AN/AN/A
Next year-40.10%N/AN/AN/A
Next 5 years (per annum)2.70%N/AN/AN/A
Past 5 years (per annum)5.72%N/AN/AN/A